Patent ID: 11939314
Assignee: MERCK PATENT GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. Compounds of the formula I, in which
X1, X2, X3, X4 each, independently of one another, denote CH or N,
Y denotes N or CH,
Q denotes H or CH3,
R1 denotes H, F, Cl, Br, CN, CH3, CF3 or OCH3,
R2 denotes H, F or Cl,
R3 denotes phenyl, naphthyl, pyridyl, pyrimidinyl, quinolinyl, isoquinolinyl, indolyl, indazolyl, thiophenyl, dihydroisoindolyl or benzimidazolyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, CN, NO2, A, (CR4)nOR4, (CR4)nN(R4)2, (CR4)nS(O)mR4, (CR4)nCON(R4)2, (CR4)nCOHet, (CR4)nSO2N(R4)2, (CR4)nSO2Het, (CR4)nN(R4)2, (CR4)nHet, O(CR4)nCOHet, (CR4)nO(CR4)nHet, (CR4)nN(R4)(CR4)nHet, (CR4)nCON(R4)(CR4)nHet, (CR4)nCON(R4)(CR4)nN(R4)2, (CR4)nN(R4)COA, (CR4)nN(R4)COHet′, (CR4)nOCyc and/or (CR4)nCOOR4,
R4denotes H or A′,
A denotes unbranched or branched alkyl with 1-10 C-atoms, wherein two adjacent carbon atoms may form a double bond and/or one or two non-adjacent CH- and/or CH2- groups may be replaced by N-, O- and/or S-atoms and wherein 1-7 H-atoms may be replaced by R5, or cyclic alkyl having 3-7 C atoms,
A′ denotes unbranched or branched alkyl with 1-6 C-atoms, wherein one or two non-adjacent CH- and/or CH2-groups may be replaced by O-atoms,
Cyc denotes cyclobutyl, cyclopentyl or cyclohexyl, each of which is unsubstituted or mono- or disubstituted by A, Hal, OR4, N(R4)2, Het′, (CR4)nO(CR4)nHet′, CON(R4)2 and/or ═O,
R5 denotes F, Cl or OH,
Het denotes pyrrolidinyl, morpholinyl, piperidinyl, piperazinyl, [1,4]-diazepanyl, oxazolidinyl, hexahydro-pyrrolo[3,4-c]pyrrolyl, 2-oxa-6-aza-spiro[3.4]octanyl, 2-oxa-6-aza-spiro[3.5]nonanyl, 2-oxa-7-aza-spiro[3.5]nonanyl, 2,5-dioxa-8-aza-spiro[3.5]nonanyl, oxetanyl, 2-oxa-5-aza-spiro[3.4]octanyl, 2-oxa-6-aza-spiro[3.3]heptanyl, 3-aza-bicyclo[3.1.0]hexanyl, 2-oxa-7-aza-spiro[3.5]nonanyl, isoxazolidinyl, azetidinyl, 2,6-diaza-spiro[3.4]octanyl, hexahydro-pyrrolo[3,4-b]pyrrolyl, tetrahydrofuranyl or isothiazolidinyl, each of which is unsubstituted or mono-, di- or trisubstituted by A, Hal, OR4, OCOA, COA, (CR4)nN(R4)2, (CR4)nHet′, (CR4)nO(CR4)nHet′, CON(R4)2, COHet′, (CR4)nS(O)mR4, and/or ═O,
Het′ denotes pyrrolidinyl, morpholinyl, piperidinyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyridyl, pyrazolyl or piperazinyl, each of which is unsubstituted or mono- or disubstituted by A, Hal, OR4, N(R4)2 and/or ═O,
Hal denotes F, Cl, Br or I,
n denotes 0, 1, 2 or 3,
m denotes 0, 1 or 2, with the proviso that no more than two of X1, X2, X3, X4, denote N, and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.